Speech-Language Pathologists in Jamestown, ND Accepting Medicare

28 Speech-Language Pathologists found. Showing 1 - 20

Laurie Anne Schauer Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850    Fax: 701-952-5154

Adeline Eamon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-568-5175

Lori Dawn Love Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850    Fax: 701-952-5154

Stephanie Joy Nelson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850    Fax: 701-952-5154

James Harold George Bergman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850

Ashley Ann Boom, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 2nd Ave Sw, Jamestown, ND 58401 Phone: 701-252-6066

Andy Kolff Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd Ave Se, Jamestown, ND 58401 Phone: 701-252-3376

Kristy L. Lorenz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 2nd Ave Ne, Suite 215a, Jamestown, ND 58401 Phone: 701-252-6066

Lonna Schmidt, MST-CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-952-5142    Fax: 701-952-1450

Stephanie Kay Lilleberg, M. S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-952-5142

Mrs. Tristy Lynn Carroll, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 2nd Ave Sw Ste 215a, Jamestown, ND 58401 Phone: 701-320-6488    Fax: 701-252-6074

Joni Elaine Hanson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850

Brittany Marie Mildenberger Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd Ave Se, Jamestown, ND 58401 Phone: 701-252-3376    Fax: 701-252-3376

Jodell Stading Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd Ave Se, Jamestown, ND 58401 Phone: 701-252-3376

Gina Marie Horgan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 3rd St Nw, Jamestown, ND 58401 Phone: 701-252-3850    Fax: 701-952-5154

Sheila Nelson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd Ave Se, Jamestown, ND 58401 Phone: 701-252-3376

Madelyn Sarah Hunt, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 2nd Ave Sw, Jamestown, ND 58401 Phone: 701-252-6066    Fax: 701-252-6074

Sheena Neys Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 2nd Ave Se, Jamestown, ND 58401 Phone: 701-252-3376

Lauren Burningham, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2422 20th St Sw, Jamestown, ND 58401 Phone: 701-952-4800

Ms. Lisa Dawn Stoterau, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 19th St Ne, Jamestown, ND 58401 Phone: 701-252-5660

News Archive

Dapagliflozin with metformin reduces glycosylated hemoglobin level and body weight

Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients with type 2 diabetes inadequately controlled with metformin alone, as compared to placebo plus metformin.

Reward-motivated learning: mesolimbic activation precedes memory formation

The prospect of a paycheck, good grade, or promotion wonderfully concentrates the mind, and researchers have now identified the brain circuitry responsible for such reward-motivated learning.

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Seattle Genetics, Inc. today reported that it has been notified by Genentech, a wholly owned member of the Roche Group, that Genentech has elected to terminate the companies' collaboration agreement for dacetuzumab (SGN-40). Dacetuzumab is a monoclonal antibody targeting CD40 that has been investigated in clinical trials for non-Hodgkin lymphoma and multiple myeloma.

Pediatric hospitals can decrease bloodstream infections following low-tech rules

Pediatric hospitals can significantly decrease the number of bloodstream infections from central venous catheters by following some low-tech rules: Insert the catheter correctly and, above all, keep everything squeaky clean after that.

Read more Medical News

› Verified 4 days ago

• 1(current)
• 2